Transplant International (Aug 2024)

Post-Kidney Transplant Cancer: A Real-World Retrospective Analysis From a Single Italian Center

  • Giulia Vanessa Re Sartò,
  • Carlo Alfieri,
  • Carlo Alfieri,
  • Laura Cosmai,
  • Emilietta Brigati,
  • Mariarosaria Campise,
  • Anna Regalia,
  • Simona Verdesca,
  • Paolo Molinari,
  • Paolo Molinari,
  • Anna Maria Pisacreta,
  • Anna Maria Pisacreta,
  • Marta Pirovano,
  • Marta Pirovano,
  • Luca Nardelli,
  • Luca Nardelli,
  • Maurizio Gallieni,
  • Maurizio Gallieni,
  • Giuseppe Castellano,
  • Giuseppe Castellano

DOI
https://doi.org/10.3389/ti.2024.13220
Journal volume & issue
Vol. 37

Abstract

Read online

We describe the epidemiology of cancer after kidney transplantation (KTx), investigating its risk factors and impact on therapeutic management and survival in KTx recipients (KTRs). The association between modification of immunosuppressive (IS) therapy after cancer and survival outcomes was analyzed. We collected data from 930 KTRs followed for 7 [1–19] years. The majority of KTRs received KTx from a deceased donor (84%). In total, 74% of patients received induction therapy with basiliximab and 26% with ATG. Maintenance therapy included steroids, calcineurin inhibitors, and mycophenolate. Patients with at least one cancer (CA+) amounted to 19%. NMSC was the most common tumor (55%). CA+ were older and had a higher BMI. Vasculitis and ADPKD were more prevalent in CA+. ATG was independently associated with CA+ and was related to earlier cancer development in survival and competing risk analyses (p = 0.01 and <0.0001; basiliximab 89 ± 4 vs. ATG 40 ± 4 months). After cancer diagnosis, a significant prognostic impact was derived from the shift to mTOR inhibitors compared to a definitive IS drug suspension (p = 0.004). Our data confirm the relevance of cancer as a complication in KTRs with ATG as an independent risk factor. An individualized choice of IS to be proposed at the time of KTx is crucial in the prevention of neoplastic risk. Finally, switching to mTORi could represent an important strategy to improve patient survival.

Keywords